PIONEERING PRODUCTION AND DELIVERY SOLUTIONS TO ADDRESS THE COMPLEXITIES OF CELL THERAPY
PIONEERING PRODUCTION AND DELIVERY SOLUTIONS TO ADDRESS THE COMPLEXITIES OF CELL THERAPY Regardless of your industry, one of the most exciting and sometimes scary aspects of creating something that has never existed before is determining where and how to begin the process — as well as how to evolve and maintain the relevancy of what you are creating. In the early days of cell therapy, one of the biggest challenges was the management and streamlining of a process that required a very rigorous timeline in order to be effective. More than a decade ago Dendreon Pharmaceuticals (Seal Beach, Calif.) set out to create an infrastructure system that would do just that, thus establishing a process to deliver complex therapies that serves as a blueprint to this day. We created an entirely new therapeutic category in 2010 with FDA-approval of the industry’s first personalized cell therapy(also called immunotherapy)for men with advanced prostate cancer. The immunotherapy treatment process b